Cite
HARVARD Citation
Eshleman, S. et al. (2022). Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. Journal of infectious diseases. pp. 1741-1749. [Online].